TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IDYA

Ideaya Biosciences Inc

Healthcare · Biotechnology

37.40$ -1.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IDYA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +452.3% +17.0% +164.0% +27.9% +1.7% +67.4% +73.1% -1.3%
– +567.8% +12.1% +183.9% -13.0% +47.6% +43.8% +29.5% -3.3%
– +244.0% +66.1% +111.5% +27.8% -25.4% +128.8% -46.3% +33.7%
– +583.8% +10.0% +186.6% -13.0% +47.8% +43.9% +28.8% -5.5%
– – – – -41.2% -80.9% -91.5% -83.3% +199,000.0%
– – – – – – – – –
– +37.6% +88.3% -2.3% -49.7% +36.7% – – –
– – – – – – – – –
– – – – – – – – –
– +338.0% -91.3% +693.5% -20.2% -51.8% -26.7% +130.1% +33.0%
– +122.4% +28.2% +456.8% +16.9% -29.8% -14.6% +70.0% +27.7%
– – – +34.5% +10.3% +10.1% -6.6% -82.9% +13.8%
– +114.0% -50.0% +34.4% +120.4% +103.8% +54.2% +133.7% +14.0%
– -100.0% – – – – – – –
– – – +97.5% +52.1% +15.9% +77.7% +70.5% -3.4%
– – – – – – – – –
– +0.0% +42.1% +22.2% +42.6% +17.6% +38.8% +42.0% +8.3%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?